SR

Active Director Director DIN 07768613
DIN 07768613 First appointment May 2017 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value •••• Premium profile

About Soma Rani

Data last updated:

Soma Rani is a Director at Panleen Universal Cures Private Limited (since 2017). The company operates in Chemicals. Panleen Universal Cures Private Limited reported revenue of ₹5.9 Lakh (FY 2025).

DIN 07768613
Primary Designation Director
Industry Chemicals
First Appointment 16 May 2017
Oldest Company Age 9 yrs
Largest company Panleen Universal Cures Private Limited · ₹5.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 May 20172017₹5.9 Lakh (FY 2025)Active

Board colleagues of Soma Rani

NameDINCompanyDesignation
Poonam Jakhmola11227014Panleen Universal Cures Private LimitedDirector

Directorship timeline

Open interactive timeline →
Panleen Universal Cures Private Limited
Premium access

Shareholding and investment profile for Soma Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Soma Rani

Soma Rani currently holds 1 directorship: Panleen Universal Cures Private Limited (Director, since 16 May 2017, revenue ₹5.9 Lakh (FY 2025)).

Soma Rani was first appointed on 16 May 2017 as Director at Panleen Universal Cures Private Limited.

The current boards of Soma Rani's companies include Poonam Jakhmola (Panleen Universal Cures Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available